BACKGROUND: Left ventricular assist devices (LVADs) are increasingly being used to treat patients in end-stage heart failure (HF) as bridge-to-transplantation, lifetime support or destination therapy. However, the importance of this newer technique for chronic cardiac support compared to heart transplantation is still open to discussion. To date, there are few studies that extensively explore the psychological and cognitive profiles of patient with ventricular assist devices (VADs). METHODS: We studied the psychological aspects, quality of life (QOL) and cognitive profiles of 19 patients with HF before VAD implantation and then at two, five and 16 months post-implantation. RESULTS: Our results showed that after VAD implantation, patients did not show any psychopathological problems such as anxiety and/or depression. More interestingly, despite the constant risk of neurological events determined by the continuous-blood-flow pump (CBFP), patients' cognitive functioning did not worsen. In fact, significant enhancements were observed over time. CONCLUSIONS: Psychological and cognitive deficits are common in advanced HF and often worsen over time. Appropriately designed and randomized studies are needed to demonstrate whether earlier VAD implantation is warranted to arrest cognitive decline and encourage better post-implantation adaptation.
BACKGROUND: Left ventricular assist devices (LVADs) are increasingly being used to treat patients in end-stage heart failure (HF) as bridge-to-transplantation, lifetime support or destination therapy. However, the importance of this newer technique for chronic cardiac support compared to heart transplantation is still open to discussion. To date, there are few studies that extensively explore the psychological and cognitive profiles of patient with ventricular assist devices (VADs). METHODS: We studied the psychological aspects, quality of life (QOL) and cognitive profiles of 19 patients with HF before VAD implantation and then at two, five and 16 months post-implantation. RESULTS: Our results showed that after VAD implantation, patients did not show any psychopathological problems such as anxiety and/or depression. More interestingly, despite the constant risk of neurological events determined by the continuous-blood-flow pump (CBFP), patients' cognitive functioning did not worsen. In fact, significant enhancements were observed over time. CONCLUSIONS: Psychological and cognitive deficits are common in advanced HF and often worsen over time. Appropriately designed and randomized studies are needed to demonstrate whether earlier VAD implantation is warranted to arrest cognitive decline and encourage better post-implantation adaptation.
Entities:
Keywords:
Left ventricular assist device (LVAD); cognitive functions; emotional profile; heart transplantation; quality of life (QOL)
Authors: Ralph J Petrucci; Joseph G Rogers; Laura Blue; Colleen Gallagher; Stuart D Russell; Dzifa Dordunoo; Brian E Jaski; Suzanne Chillcott; Benjamin Sun; Tammy L Yanssens; Antone Tatooles; Lalig Koundakjian; David J Farrar; Mark S Slaughter Journal: J Heart Lung Transplant Date: 2012-01 Impact factor: 10.247
Authors: G Zuccalà; C Cattel; E Manes-Gravina; M G Di Niro; A Cocchi; R Bernabei Journal: J Neurol Neurosurg Psychiatry Date: 1997-10 Impact factor: 10.154
Authors: A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates Journal: Am J Med Date: 1996-09 Impact factor: 4.965
Authors: Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte Journal: J Heart Lung Transplant Date: 2009-10-17 Impact factor: 10.247
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2013-02 Impact factor: 10.247
Authors: Marykay A Pavol; Joshua Z Willey; Ying Wei; Melana Yuzefpolskaya; Randolph S Marshall; Philip J Marascalco; Jason Harwood; Ronald M Lazar Journal: Gen Thorac Cardiovasc Surg Date: 2018-05-23
Authors: Himali Weerahandi; Nathan Goldstein; Laura P Gelfman; Ulrich Jorde; James N Kirkpatrick; Edith Meyerson; Judith Marble; Yoshifumi Naka; Sean Pinney; Mark S Slaughter; Emilia Bagiella; Deborah D Ascheim Journal: J Pain Symptom Manage Date: 2017-08-12 Impact factor: 3.612
Authors: Timothy J Fendler; John A Spertus; Kensey L Gosch; Philip G Jones; Jared M Bruce; Michael E Nassif; Kelsey M Flint; Shannon M Dunlay; Larry A Allen; Suzanne V Arnold Journal: Circ Cardiovasc Qual Outcomes Date: 2015-04-29
Authors: Wendy E Balliet; Alok Madan; Michael L Craig; Eva R Serber; Jeffery J Borckardt; Christine Pelic; Kelly Barth; Anthony Hale; Adrian B van Bakel; Jennifer L Peura Journal: J Cardiovasc Nurs Date: 2017 Mar/Apr Impact factor: 2.083
Authors: Eric J Connors; Alexander O Hauson; Brianna D Barlet; Sharis Sarkissians; Nicholas P Stelmach; Alyssa D Walker; Natasha M Nemanim; Kristina L Greenwood; Nicholas J Chesher; Scott C Wollman; Kenneth E Allen; Matthew G Hall; Christopher Flora-Tostado Journal: Neuropsychol Rev Date: 2021-01-11 Impact factor: 7.444
Authors: Anita L Slade; Margaret E O'Hara; David Quinn; Laura Marley; Stephen Griffith; Melanie Calvert; M Sayeed Haque; Hoong Sern Lim; Philippa Doherty; Deirdre A Lane Journal: PLoS One Date: 2022-09-21 Impact factor: 3.752
Authors: Ayan Sen; Joel S Larson; Kianoush B Kashani; Stacy L Libricz; Bhavesh M Patel; Pramod K Guru; Cory M Alwardt; Octavio Pajaro; J Christopher Farmer Journal: Crit Care Date: 2016-06-25 Impact factor: 9.097